Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

11.04
+0.02000.18%
Volume:160.27K
Turnover:1.78M
Market Cap:421.94M
PE:-4.39
High:11.43
Open:11.01
Low:10.84
Close:11.02
52wk High:13.82
52wk Low:4.93
Shares:38.22M
Float Shares:21.58M
Volume Ratio:0.95
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.5151
EPS(LYR):1.68
ROE:-27.11%
ROA:-15.71%
PB:1.24
PE(LYR):6.57

Loading ...

Jan 08, 2026

Major Issues Report

Form 8-K - Current report
Nov 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 14, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 06, 2025

Major Issues Report

Form 8-K - Current report
Aug 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2025

Major Issues Report

Form 8-K - Current report
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 01, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 11, 2025

Major Issues Report

Form 8-K - Current report
Jun 03, 2025

Major Issues Report

Form 8-K - Current report
May 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 30, 2025

Major Issues Report

Form 8-K - Current report